Assessing the Impact of Overdose Prevention Centers as a Polysubstance Use and Behavioral Health Intervention in New York City
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Overdose
- Sponsor
- NYU Langone Health
- Enrollment
- 500
- Locations
- 1
- Primary Endpoint
- Incidence of Psychiatric Services Utilization
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
The aims of this study are: (Aim 1) Identify sources of heterogeneous impacts of opioid prevention center (OPC) use on non-fatal and fatal overdose risk among individuals with histories of polysubstance use (PSU); (Aim 2) Estimate the impact of OPC use on treated psychiatric events among clients with histories of PSU, and; (Aim 3) Assess the barriers and facilitators of integrating mental health services into existing syringe service and OPC delivery models.
Detailed Description
Aims 1 and 2 of this study will use secondary data to identify sources of heterogeneous impacts of OPC use on fatal and nonfatal overdose risk (Aim 1) and estimate the impact of OPC use on treated psychiatric events among clients with histories of PSU (Aim 2). Aim 3 of this study will use qualitative interviews with harm reduction staff to assess barriers and facilitators of integrating mental health services into existing syringe service and OPC delivery models.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Aims 1 and 2:
- •are 18 years of age or older;
- •engaged in syringe service program and/or overdose prevention center services in New York City in the past 30 days before the date of enrollment;
- •are able to complete assessments in English or Spanish;
- •are competent to give written informed consent at the time of the interview;
- •are able to provide informed consent;
- •self-report use of illicit opioids (e.g., heroin, fentanyl), illicit stimulants (e.g., powder cocaine, crack, methamphetamine), counterfeit prescription pills (defined as prescription pills obtained through the illicit drug market) or any injection drug use in the past 30 days, and
- •are able to participate for at least 6 months following enrollment.
- •are 18 years of age or older;
- •are employed by a harm reduction program;
Exclusion Criteria
- •Individuals not meeting the criteria detailed above for the respective Aims will not be eligible for participation in this study.
Outcomes
Primary Outcomes
Incidence of Psychiatric Services Utilization
Time Frame: Up to Month 12
Psychiatric services utilization will be assessed from SPARCS, RHIO, and NYS Medicaid.
Incidence of Fatal Overdose
Time Frame: Up to Month 12
Incidence of fatal overdose will be derived from overdose mortality data from the NYC Office of the Chief Medical Examiner.
Incidence of Non-Fatal Overdose
Time Frame: Up to Month 12
Incidence of nonfatal overdose will be assessed using hospitalization and emergency department data from the NYC Regional Health Information Exchange (RHIO) and Statewide Research and Planning Cooperative System (SPARCS).